Zhitong Finance App News, Tianyu Co., Ltd. (300702.SZ) issued an announcement. Zhejiang Nuode Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, participated in the bidding process for the 12th batch of centralized national drug procurement organized by the State Organization Drug Joint Procurement Office (“Joint Procurement Office”). According to the “Announcement of the 12th Batch of National Organization Drug Centralized Volume Procurement Proposed Selection Results” published by the Joint Procurement Office on July 31, 2026 on the Shanghai Sunshine Pharmaceutical Procurement Network, the company's products, trazodone hydrochloride tablets and edoxaban tablets, were selected for centralized procurement.

The procurement period for the products to be selected is from the date of execution of the selected results to December 31, 2029. If the subsequent procurement contract is successfully signed and implemented, it is expected that the product's sales volume and market share will be further increased, and the company's brand influence will be enhanced.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.